Fund Management At Engine No. 1 LLC Eli Lilly & CO Transaction History

Fund Management At Engine No. 1 LLC

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Nov 14, 2023	BUY	$434.7 - $599.3 $498,600 - $687,397	1,147 Added 11.18%	11,405 $6.13 Million
Q2 2023 Aug 14, 2023	BUY	$350.74 - $468.98 $243,062 - $325,003	693 Added 7.25%	10,258 $4.81 Million
Q1 2023 May 12, 2023	BUY	$310.63 - $364.82 $274,286 - $322,136	883 Added 10.17%	9,565 $3.28 Million
Q4 2022 Feb 13, 2023	BUY	$321.55 - $374.67 $353,383 - $411,762	1,099 Added 14.49%	8,682 $3.18 Million
Q3 2022 Nov 14, 2022	SELL	$296.48 - $337.87 $112,662 - $128,390	-380 Reduced 4.77%	7,583 $2.45 Million
Q2 2022 Aug 12, 2022	BUY	$278.73 - $327.27 $345,903 - $406,142	1,241 Added 18.46%	7,963 $2.58 Million
Q1 2022 May 13, 2022	BUY	$234.69 - $291.66 $1.58 Million - $1.96 Million	6,722 New	6,722 $1.93 Million

4,004

752M

8.27M

10.5M

Ticker LLY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 950,174,976
Market Cap $711B
Description
Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...

Get notified when there are updates to the investment portfolio of Fund Management At Engine No. 1 LLC, based on Form 13F filings with the SEC.

Stay updated on Fund Management At Engine No. 1 LLC with notifications on news.